Form 8-K - Current report:
SEC Accession No. 0001021408-02-013515
Filing Date
2002-11-12
Accepted
2002-11-12 08:05:44
Documents
3
Period of Report
2002-10-31
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 123775
3 AMD. #1 TO ASSET PURCHASE AGREEMENT dex1092.htm EX-10.92 15714
4 PRESS RELEASE dex991.htm EX-99.1 4256
  Complete submission text file 0001021408-02-013515.txt   145716
Mailing Address PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-27410 | Film No.: 02815050
SIC: 2834 Pharmaceutical Preparations